Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-22 7:22 pm Sale |
2021-04-13 | 13D | Karuna Therapeutics, Inc. KRTX |
ARCH Venture Fund IX, L.P. | 2,946,891 10.000% |
-135,744 (-4.40%) |
Filing History |
| 2021-04-14 5:23 pm Sale |
2021-03-30 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 26,690,617 20.900% |
-1,976,046 (-6.89%) |
Filing History |
| 2021-02-02 4:13 pm Purchase |
2020-12-31 | 13G | Beam Therapeutics Inc. BEAM |
ARCH Venture Fund IX, L.P. | 8,243,039 13.500% |
8,243,039 (New Position) |
Filing History |
| 2021-01-19 1:25 pm Sale |
2021-01-08 | 13D | Karuna Therapeutics, Inc. KRTX |
ARCH Venture Fund IX, L.P. | 3,082,635 11.500% |
-280,237 (-8.33%) |
Filing History |
| 2020-07-29 3:50 pm Unchanged |
2020-07-08 | 13D | Vir Biotechnology, Inc. VIR |
ARCH Venture Fund IX, L.P. | 28,666,663 23.000% |
0 (Unchanged) |
Filing History |